Results for tag: "Cytomegalovirus"

The Cytomegalovirus (CMV) market is a segment of the healthcare services industry that focuses on the diagnosis, treatment, and prevention of CMV infections. CMV is a common virus that can cause serious health problems in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and newborns. Diagnosis of CMV is typically done through blood tests, urine tests, and other laboratory tests. Treatment of CMV infections can include antiviral medications, such as ganciclovir and valganciclovir, as well as supportive care. Prevention of CMV infections can include vaccination, antiviral prophylaxis, and other preventive measures. Some companies in the CMV market include Gilead Sciences, Inc., Merck & Co., Inc., Pfizer, Inc., and GlaxoSmithKline plc. Show Less Read more